Kingsley Biotechnology (01548): Net trade sales of CARVYKTI® in the second quarter were approximately US$657 million

Zhitongcaijing · 3d ago

Zhitong Finance App News, Kingsley Biotech (01548) announced that according to the cooperation and licensing agreement between Legend and Janssen Biotech, Inc. (Janssen) on December 21, 2017, CARVYKTI® generated net trade sales of approximately US$657 million for the quarter ended June 30, 2026.